Dysregulation of regulatory CD56 (bright) NK cells/T cells interactions in multiple sclerosis

被引:0
|
作者
Laroni, A. [1 ,2 ]
Armentani, E. [1 ]
de Rosbo, N. K. [1 ]
Ivaldi, F. [1 ]
Marcenaro, E. [1 ]
Sivori, S. [1 ]
Gandhi, R. [3 ,4 ]
Weiner, H. L. [3 ,4 ]
Moretta, A. [1 ]
Mancardi, G. L. [1 ,2 ]
Uccelli, A. [1 ,2 ]
机构
[1] Univ Genoa, Genoa, Italy
[2] IRCCS San Martino IST, Genoa, Italy
[3] Harvard Med Sch, Boston, MA USA
[4] Brigham & Womens Hosp, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
O8.08
引用
收藏
页码:57 / 57
页数:1
相关论文
共 50 条
  • [31] Oncolytic virus treatment differentially affects the CD56(dim) and CD56(bright) NK cell subsets in vivo and regulates a spectrum of human NK cell activity
    Wantoch, Michelle
    Wilson, Erica B.
    Droop, Alastair P.
    Phillips, Sarah L.
    Coffey, Matt
    El-Sherbiny, Yasser M.
    Holmes, Tim D.
    Melcher, Alan A.
    Wetherill, Laura F.
    Cook, Graham P.
    IMMUNOLOGY, 2022, 166 (01) : 104 - 120
  • [32] Activated T cells and cytokine-induced CD3(+)CD56(+) killer cells
    SchmidtWolf, GD
    Negrin, RS
    SchmidtWolf, IGH
    ANNALS OF HEMATOLOGY, 1997, 74 (02) : 51 - 56
  • [33] CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells
    Jacobs, R
    Hintzen, G
    Kemper, A
    Beul, K
    Kempf, S
    Behrens, G
    Sykora, KW
    Schmidt, RE
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2001, 31 (10) : 3121 - 3127
  • [34] CD56bright NK cells mediate immunomodulatory effects of IL-2R-alpha-targeted therapy in multiple sclerosis
    Bielekova, B
    Reichert-Scrivner, S
    Cerna, A
    McFarland, H
    Martin, R
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 211 - 211
  • [35] CD56 negative NK cells: origin, function, and role in chronic viral disease
    Bjorkstrom, Niklas K.
    Ljunggren, Hans-Gustaf
    Sandberg, Johan K.
    TRENDS IN IMMUNOLOGY, 2010, 31 (11) : 401 - 406
  • [36] CD56bright human NK cells differentiate into CD56dim cells:: Role of contact with peripheral fibroblasts
    Chan, Antoni
    Hong, Deng-Li
    Atzberger, Ann
    Kollnberger, Simon
    Filer, Andrew D.
    Buckley, Christopher D.
    McMichael, Andrew
    Enver, Tariq
    Bowness, Paul
    JOURNAL OF IMMUNOLOGY, 2007, 179 (01): : 89 - 94
  • [37] CD4 and CD8 regulatory T cells in multiple sclerosis
    Karandikar, Nitin J.
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 203 (02) : 260 - 260
  • [38] Differential cytokine production by T cells that are positive or negative for CD56
    Rogers, JK
    Doherty, DG
    IMMUNOLOGY 2004: CYTOKINE NETWORK, REGULATORY CELLS, SIGNALING, AND APOPTOSIS, 2004, : 109 - 114
  • [39] CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells
    Vukicevic, Marija
    Chalandon, Yves
    Helg, Claudine
    Matthes, Thomas
    Dantin, Carole
    Huard, Bertrand
    Chizzolini, Carlo
    Passweg, Jakob
    Roosnek, Eddy
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (11) : 3246 - 3254
  • [40] Successful therapy of multiple sclerosis (MS) targeting high-affinity IL-2 receptor reveals regulatory role of CD56bright NK cells on T cell responses in humans
    Bielekova, B.
    Catalfamo, M.
    Reichert-Scrivner, S.
    Packer, A.
    Cerna, M.
    Waldmann, T. A.
    McFarland, H.
    Henkart, P.
    Martin, R.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 54 - 54